BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:19 PM
 | 
Feb 06, 2008
 |  BC Extra  |  Top Story

FDA panel backs Zyprexa LAI

FDA's Psychopharmacologic Drugs Advisory Committee on Wednesday voted that Zyprexa long-acting injection (LAI) from Eli Lilly (NYSE:LLY) is safe and effective for the treatment and maintenance treatment of schizophrenia in adults despite agency concerns about reports of injection-related...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >